In this large prospective cohort of postmenopausal women in the U.S., we hypothesized that the anti-HT medications that hamper RAGE inflammatory signaling would be associated with reduced risk of pancreatic cancer. The gene discussed is AGER; the disease is familial pancreatic carcinoma.